Bavarian Nordic (OTCPK:BVNRY) has received FDA approval for its vaccine Vimkunya for the prevention of chikungunya. The virus-like particle, or VLP, vaccine is approved for people aged 12 and older.
According to the Hospital Central del Instituto de Previsión Social (IPS), about 30% of its staff is on bed rest after being diagnosed with chikungunya. “We estimate that 30 % of our staff is ...
Colombo, February 4 (Daily Mirror) - Sri Lanka is experiencing a rise in Chikungunya cases, with the highest number of infections being reported across the country. Paediatrician at Lady Ridgeway ...
Bavarian Nordic’s chikungunya vaccine Vimkunya is one step closer to being available in Europe after having secured an ...
En ambos casos, la región más afectada es América y, en concreto, el chikungunya se encuentra más extendido en Brasil, Paraguay y Colombia. En Europa continental, el riesgo de transmisión de ...
A definitive diagnosis of Chikungunya infection can be made only with the aid of laboratory support since clinically, symptoms resemble those of dengue fever. Laboratory diagnosis is therefore ...
El Centro Europeo para la Prevención y el Control de Enfermedades (ECDC) ha dado a conocer los últimos datos referentes al panorama mundial del dengue y el Chikungunya. Ambas afecciones han registrado ...
a) Estadística descriptiva o deductiva: se basa en la recolección de datos y su clasificación, elaboración de tablas y gráficos que resumen esos datos; además, como la determinación de ...
THE CITY Health Office recorded five suspected cases of Chikungunya–a mosquito-borne viral disease considered less fatal than dengue–in the first 15 days of the year. During the iSpeak media forum on ...
The Ixchiq vaccine is also approved in the US, EU, and Canada. Credit: Taras Vykhopen via Getty Images. Valneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s Medicines and Healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback